08Aug
FDA Releases New Warning Letter on Human and Animal Hemp CBD Products
On July 22, 2019, the Food and Drug Administration (“FDA”) released its fourth warning letter for cannabidiol (“CBD”) related products since the enactment of the 2018 Federal Farm Bill in December. Though not a formal action or rule-making by the...
By:
Miller & Martin PLLC
Related
In today’s edition of Daily Compliance News: 1. What is the cause of SFO delays? (WSJ) 2.EU looks ...
Read More >
Dangers That As A 401(k) Provider You Need To Avoid. In an instant, it can all be gone. It can tak...
Read More >
The U.K. Competition and Markets Authority has issued the Investment Consultancy and Fiduciary Manag...
Read More >
After months of confusion and pain surrounding the topic of independent contractors, we are practica...
Read More >
You signed a construction contract in February. Then, in March, the world as we know it changed due ...
Read More >
Generally, indemnity agreements in construction contracts are a promise by which one party (the inde...
Read More >